Literature DB >> 6630201

Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine.

Y Nakagawa, V Abram, F J Kézdy, E T Kaiser, F L Coe.   

Abstract

Using an assay of the rate of crystal growth of calcium [14C]oxalate monohydrate, we ascertained that the factor responsible for more than 90% of the crystal growth inhibition in human urine is a nondialyzable macromolecule. We have purified this factor using DEAE-cellulose chromatography, followed by Bio-Gel P-10 column chromatography with 50% formamide as the eluent, and finally by gel permeation chromatography. About 5 mg of the inhibitor was obtained from normal 24-h adult urine, with 16% recovery of the original inhibitory activity. The inhibitor isolated was found to be a highly acidic glycoprotein with Mr = 1.4 X 10(4). It is rich in acidic amino acids, including gamma-carboxyglutamic acid, and contains few aromatic and basic amino acids. Two or three phosphate groups are covalently linked to the inhibitor. In the presence of the inhibitor, the kinetics of calcium oxalate monohydrate crystal growth inhibitor showed that the macromolecule binds to the crystal surface according to a Langmuir adsorption isotherm with a dissociation constant, Kd = 5.3 X 10(-7) M. The inhibitor readily formed an insoluble monolayer at the air-water interface and showed an unusually high surface stability with a collapse pressure of 41.5 dynes/cm. The urinary inhibitor closely resembled in all properties the calcium oxalate monohydrate crystal growth inhibitor that we had isolated from human embryonic kidney tissue culture medium (Nakagawa, Y., Margolis, H. C., Yokoyama, S., Kézdy, F. J., Kaiser, E. T., and Coe, F. L. (1981) J. Biol. Chem. 256, 3936-3944).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The many roles of oxalate in nature.

Authors:  Lynwood H Smith
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

2.  Interaction between nephrocalcin and calcium oxalate monohydrate: a structural study.

Authors:  S Deganello
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

3.  Urinary crystal surface binding substances on calcium oxalate crystals.

Authors:  T Koide; T Yoshioka; S Yamaguchi; S Hosokawa; M Utsunomiya; T Sonoda
Journal:  Urol Res       Date:  1990

4.  An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine.

Authors:  S Sørensen; K Hansen; S Bak; S J Justesen
Journal:  Urol Res       Date:  1990

5.  The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine.

Authors:  M D Gohel; D K Shum; M K Li
Journal:  Urol Res       Date:  1992

6.  Effects of urinary macromolecules on the crystallization of calcium oxalate.

Authors:  H G Tiselius; A M Fornander; M A Nilsson
Journal:  Urol Res       Date:  1990

7.  Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers.

Authors:  F Atmani; B Lacour; P Jungers; T Drüeke; M Daudon
Journal:  Urol Res       Date:  1994

8.  Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.

Authors:  Y Nakagawa; V Abram; J H Parks; H S Lau; J K Kawooya; F L Coe
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition.

Authors:  Jack G Kleinman; Laura J Alatalo; Ann M Beshensky; Jeffrey A Wesson
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

10.  Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss.

Authors:  M H Knapen; K S Jie; K Hamulyák; C Vermeer
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.